Ministry of Health Belize


Mar 23rd
Text size
  • Increase font size
  • Default font size
  • Decrease font size
Home Documents Belize National Formulary

Belize National Formulary and Theraputic Manual

E-mail Print PDF

The ninth edition of the Belize National Formulary is being reviewed five years after the previous edition of 2002. In 2002 a review of the formulary was conducted with a consultancy by the consultant of the Barbados Drug Service, Ms. Pamela Payne. From that consultancy an essential Drugs list was developed, but there was no manual produced due to administrative difficulties.  This edition of the formulary was conducted under the directorship of the Chief Pharmacist/ Technical Advisor of the Ministry of Health Mrs. Sharon Sanchez-Anderson and her competent team of Pharmacists and Doctors(Mr. Anslem Anene, Mrs. Samira Gongora , Mr. Eugene Echegi, Mrs. Dana El-Amin, Ms. Angella Ebuta,Dra. Adelita Ghazy, Mrs. Sharon Sanchez-Anderson along with Dr. Fernando Cuellar and Dr. Jesus Ken), all Belizean Nationals and past Nigerian Technical Aid Corps representatives. Pharmaceuticals have assumed an increasing important role in the management of many diseases and therefore the rational use of medication provides an efficacious and cost effective means of treating these diseases. The design and layout of the text has been adopted from the World Health Organization model formulary to produce an updated, more user friendly and attractive quick reference guide. The formulary committee revised submissions by all specialties and eventually agreed on sixty-nine (69) product additions and twelve (12) deletions during a two days stake holder’s workshop held to obtain the final consensus on the list of drugs to be added and deleted. The drug listed in the formulary corresponds to the health care needs of the vast majority of the population taking into consideration the prevailing economic climate. A selected list of different drug products has an important influence on several key fiscal administrative and quality control requirements of the pharmaceutical logistics system.

With regards to drug procurement, purchasing power is greatly enhanced by the elimination of duplicate and non-essential products. On the clinical side, doctors are assured that the most effective and safe drugs (Drug of Choice) were selected for inclusion. It must be emphasized that the adoption of the formulary is not and arbitrary administrative or economic measure, but a therapeutically oriented tool to increase the availability of essentials drugs. However, in order for a drug formulary to exert its maximum impact on the care and cost of requirement of the health care system, its implementation and use must be mandated by regulation. I trust, therefore, that my peer and other health care providers will strictly adhere to the drugs listed in this formulary bearing in mind that provision has been made for specially authorized drugs (SAD) in exceptional cases…..

Sharon Sanchez-Anderson (Mrs.)
Chief Pharmacist./Technical Advisor
Ministry of Heath